Results indicate a need for providers to ask depressed patients about their marijuana use.
A rise in overdose deaths is associated with overprescribing of opioid analgesic medications.
Fewer people believe marijuana is harmful.
Δ9-Tetrahydrocannabinol (THC) is the main psychoactive chemical ingredient in cannabis.
The report also sheds light on the most significant predictors of substance abuse.
The increased use of synthetic cannabinoids presents a serious public health threat.
Alterations in reward processing may increase users' risk of continued drug use and subsequent addiction.
Chronic and severe cannabis-dependence is associated with deficits in striatal dopamine release.
Marijuana use is associated with development of various neuropsychiatric conditions such as schizophrenia, anxiety, and depression.
Tetrahydrocannabinol (THC) is the main active chemical ingredient found in cannabis and is a potent cannabinoid receptor (CB)-1 agonist.
Prolonged cannabis use is a risk factor for periodontal disease.
Study links heavy cannabis use in male teens to increased mortality by age 60.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Prazosin May Be Effective as Treatment for Alcohol Use Disorder
- Panel Recommends Earlier Body Weight Monitoring in Use of Mood Stabilizers
- Nondaily Cigarette Use Increasing Among Individuals With Mental Health, Substance Use Disorders
- Cesarean Delivery, Early Childhood Antibiotic Use Not Associated With Risk for ADHD
- Uncertainty as a Form of Violence: Current Immigration Policy and Crisis
- FDA Gets Tough on Juul, Other Electronic Cigarette Makers